DeepVessel closes RMB150m Series B+ led by GGV

On August 13, DeepVessel, China’s first medical AI certificate of three types of certified enterprises announced the completion of its Series B+ round of strategic financing worth 150 million yuan. This round was led by GGV Capital, with participation from Kunlun, Guofang fof and Yahui Capital.

On August 13, DeepVessel, China’s first medical AI certificate of three types of certified enterprises announced the completion of its Series B+ round of strategic financing worth 150 million yuan. This round was led by GGV Capital, with participation from Kunlun, Guofang FOF and Yahui Capital.

Proceeds from this round of financing will be used to complete the commercial launch of CMA’s products globally and provide a key driver for subsequent brand upgrades, product development and market expansion.

As a company with cardiovascular AI as its main product, DeepVessel is currently promoting the coronary vascular disease accurate diagnosis product line and intelligent imaging solutions, with an emphasis on PAAS layer applications.

Among them, the coronary blood flow reserve fraction calculation software independently developed by the company has passed the approval of the Instrument Review Center, becoming China’s first approved artificial intelligence medical device of Class III, and the only product with dual certification of China’s NMPA and EU’s CE.

The three main application categories of DeepVessel are public hospitals, private hospitals and third-party markets. To date, the company has established cooperation with more than 200 public hospitals, and jointly built nearly 100 artificial intelligence diagnostic centers.

In the meantime, DeepVessel has also entered into strategic cooperation with a number of private hospitals and independent imaging centers.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/08/15/deepvessel-closes-rmb150m-series-b-led-by-ggv/.

Leave a Reply

Please Login to Comment